SD

Shreekant Dattathray Sawant

Active Director Managing Director DIN 00745968
DIN 00745968 First appointment Jul 1983 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Jul 1983
Shareholding value •••• Premium profile

About Shreekant Dattathray Sawant

Data last updated:

Shreekant Dattathray Sawant is a Managing Director at Centaur Pharmaceuticals Private Limited (since 2008) and Designated Partner at Minesfield Advisory Services Llp (since 2015). The companies operate in Pharma, Business Outsourcing and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹1,062 Cr; the largest is Centaur Pharmaceuticals Private Limited at ₹1,060 Cr (FY 2025). Earlier, Shreekant Dattathray Sawant was a Director at Chiron Realty Private Limited (2013–2014) and Director at Chikhloli Morivli Effluent Treatment (1996–2012) and 2 more.

DIN 00745968
Primary Designation Managing Director
Industry Pharma
First Appointment 29 Jul 1983
Oldest Company Age 46 yrs
Largest company Centaur Pharmaceuticals Private Limited · ₹1,060 Cr (FY 2025)
Combined revenue ₹1,062 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director01 Aug 20081980₹1,060 Cr (FY 2025)Active
Designated Partner22 Dec 20152015₹1.54 Cr (FY 2017)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chiron Realty Private Limited U45302MH2013PTC242599
Director29 Apr 20132013Amalgamated
Chikhloli Morivli Effluent Treatment U99999MH1994NPL082995
Director22 May 19961994₹1.90 Cr (FY 2025)Active
Centaur Chemicals Private Limited U24100MH1981PTC025661
Director29 Jul 19831981Amalgamated
Director09 Jun 20152013₹4 Lakh (FY 2015)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Minesfield Advisory Services Llp
Centaur Chemicals Private Limited
Centaur Pharmaceuticals Private Limited
Minesfield Advisory Services Private Limited
Premium access

Shareholding and investment profile for Shreekant Dattathray Sawant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreekant Dattathray Sawant

Shreekant Dattathray Sawant currently holds 2 directorships: Centaur Pharmaceuticals Private Limited (Managing Director, since 01 Aug 2008, revenue ₹1,060 Cr (FY 2025)); Minesfield Advisory Services Llp (Designated Partner, since 22 Dec 2015, revenue ₹1.54 Cr (FY 2017)).

Shreekant Dattathray Sawant was first appointed on 29 Jul 1983 as Director at Centaur Chemicals Private Limited. The most recent appointment on record is 22 Dec 2015 at Minesfield Advisory Services Llp.

The 2 current companies of Shreekant Dattathray Sawant that report revenue have a combined latest revenue of ₹1,062 Cr: Centaur Pharmaceuticals Private Limited ₹1,060 Cr (FY 2025); Minesfield Advisory Services Llp ₹1.54 Cr (FY 2017).

Shreekant Dattathray Sawant held 4 earlier board appointments: Chiron Realty Private Limited (Director, 29 Apr 2013 to 21 Jan 2014); Chikhloli Morivli Effluent Treatment (Director, 22 May 1996 to 28 Feb 2012); Centaur Chemicals Private Limited (Director, from 29 Jul 1983); Minesfield Advisory Services Private Limited (Director, from 09 Jun 2015).

The current boards of Shreekant Dattathray Sawant's companies include Albert Tauro (Centaur Pharmaceuticals Private Limited), Pritam Maruti Khawale (Centaur Pharmaceuticals Private Limited), Rakhi Shridhar Kadam (Centaur Pharmaceuticals Private Limited), Sharadchandra Damodar Abhyankar (Centaur Pharmaceuticals Private Limited), Shivanand Dattatray Sawant (Centaur Pharmaceuticals Private Limited), Smita Abhayakumar Phal (Centaur Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available